Skip to main content

Table 2 The KEGG pathways enriched by the potential target genes of miR-542-5p

From: The suppressive role of miR-542-5p in NSCLC: the evidence from clinical data and in vivo validation using a chick chorioallantoic membrane model

ID

Description

Count in gene set

p-value

hsa05032

Morphine addiction

11

0.000111

hsa04024

cAMP signaling pathway

15

0.000587

hsa04261

Adrenergic signaling in cardiomyocytes

12

0.001364

hsa04727

GABAergic synapse

9

0.001523

hsa05030

Cocaine addiction

7

0.001541

hsa04390

Hippo signaling pathway

12

0.001790

hsa04725

Cholinergic synapse

10

0.002243

hsa04724

Glutamatergic synapse

10

0.002693

hsa05200

Pathways in cancer

21

0.002768

hsa04923

Regulation of lipolysis in adipocytes

7

0.003081

hsa05414

Dilated cardiomyopathy

8

0.005886

hsa04911

Insulin secretion

8

0.006278

hsa04921

Oxytocin signaling pathway

11

0.007747

hsa04976

Bile secretion

7

0.008632

hsa04520

Adherens junction

7

0.009886

  1. Enriched by DAVID, p < 0.01